Economic evaluation of cancer treatments: methodological and practical issues.
Economic evaluation is a comparative analysis of alternatives in terms of both their costs and consequences. Therefore, the basic task of economic evaluation is to identify, measure, value and compare the costs and effects of the alternatives being considered. In this paper, the methodology of economic evaluation in general and in cancer in particular is reviewed and practical issues are illuminated. In the treatment of cancer patients not only survival and disease-free survival are important outcome parameters, but also quality of years alive. Hence, specific attention is given to the measurement and valuation of quality of life. Economic evaluation is intended to support health policy at different levels of decision making. In cancer treatment, health policy concerns both preventive, curative and palliative strategies, and decisions are often made at the micro and macro level. Economic evaluation can provide essential information on the costs and benefits of each option, and consequently on the optimal policy mix, and thus support decisions on the adoption and utilization of new treatments. Such information may assist policy makers in formulating regulatory policies and legislation, industry in developing products, health professionals in treating and serving patients, and consumers in making personal health decisions.
Uyl-de Groot
C A
CA
Institute for Medical Technology Assessment, Erasmus University Rotterdam, The Netherlands.
Touw
C R
CR
D003362:Cost-Benefit Analysis / Q000379:methods*; D017048:Health Care Costs; D006291:Health Policy; D006302:Health Services Research / Q000191:economics / Q000379:methods*; D009369:Neoplasms / Q000191:economics* / Q000628:therapy*; D009426:Netherlands; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D016896:Treatment Outcome; D019366:Western World